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CASE REPORTS
Previously, we reported on a patient with an
aneurysm1 who lacked type III collagen in both the
skin and aortic wall, but did not show the typical
clinical symptoms of Ehlers-Danlos syndrome
(EDS), such as hyperextensible joints and thin skin.
Cases of EDS type IV that were reported previously
were marked by a deficit of type III collagen and
hereditary disease. The patient whose case we previ-
ously reported1 may have a new form of aneurysm
with type III collagen deficiency; however, its clini-
cal features, incidence, and pathogenesis are
unknown. This new form of aneurysm was investi-
gated by analyzing the collagen extracted from skin
specimens of patients who underwent aneurysmal
surgery and examining the backgrounds of patients
with this new form of aneurysm. We did not use the
aneurysmal wall because collagen in the aneurysmal
wall is degenerated and the amount of type III col-
lagen is reduced to some degree2; therefore, we used
skin that contains types of collagen similar to those
in the aortic wall.3
CASE REPORT
It was revealed by means of the sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE)
analysis4 of the collagen extracted from the skin specimens
of the 79 patients that only 1 patient lacked type III col-
lagen (Figs 1 and 2). The patient was a 55-year-old man
who had chest pain 3 years after undergoing abdominal
aortic replacement for an abdominal aortic aneurysm. He
did not show any of the typical clinical symptoms of EDS
type IV. A Stanford type A aortic dissection was shown by
means of computed tomography (CT) of the chest, but
the false lumen of the ascending aorta was already throm-
bosed. The patient was treated medically and received fol-
low-up care; however, 5 months later, redissection was
detected by means of CT of the chest and a trans-
esophageal echocardiography. The dissection extended to
just above the aortic valve and was complicated by aortic
regurgitation (III°). The patient did not have hyperten-
sion, hyperlipidemia, or diabetes mellitus, and he did not
have a clear family history of EDS. A modified Bentall
operation5 and total aortic arch replacement was per-
formed using a Hemashield graft (Meadox Medicals,
Oakland, NJ) with a ø 23 mm Carbomedics aortic valve
(Carbomedics, Austin, Tex) under cardiopulmonary
bypass with selective cerebral perfusion. The collagen
extracted from the skin consisted of types I and III. Type
I collagen consisted of monomer of a 1(I) and dimer of
a 2(I), whereas type III collagen consisted of trimer of
a 1(III). This patient showed a lack of a 1(III) on the SDS-
PAGE (Fig 1). This deficiency was confirmed by means of
the densitometric analysis (Fig 2). The incidence of a defi-
ciency of type III collagen in this study was 1.3% (1 of 79
patients). The aortic wall that was harvested from this
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patient during the operation was also analyzed and found
to lack type III collagen. The skin specimen obtained from
this patient was prepared for transmission electron micro-
scopic analysis so the homogeneity of the collagen fibrils
could be examined. The collagen fibrils of this patient
were quite homogenic and similar to those of a control
skin specimen obtained from a 39-year-old woman with
breast cancer (Fig 3). The typical morphologic abnormal-
ities of collagen fibrils reported in EDS were not observed
in this patient. 
DISCUSSION
Classic EDS is defined as a heterogenous, inherit-
ed disorder of connective tissue with characteristical-
ly fragile hyperextensible skin, hyperextensible joints,
tissue fragility and a predisposition to paper tissue
scars. EDS is classified into 10 types according to the
biochemical profile.6 EDS type IV is characterized by
a deficiency of type III collagen and premature death
caused by large arterial and bowel rupture7; howev-
er, a number of variations of EDS type IV have been
recognized recently.8 We have encountered 2 cases;
the first was described in a previous report,1 and the
second, the subject of this paper, cannot be classified
into any of EDS type IV. Both patients suffered aor-
tic aneurysms and lacked any type III collagen in
their skin and aortic wall, but they did not have thin
skin. The clinical features of this new form of type III
collagen deficiency include a relatively young age at
the onset of aortic aneurysm, with none of the usual
risk factors. Furthermore, there was no clear family
history of EDS in either of these patients. Nearly
homogeneic findings, compared with those of previ-
ous reports, were shown by means of electron micro-
scopic examination of the collagen fibrils from the
second patient.9
Fig 1. Deficiency of type III collagen ( a 1[III]) in the
patient shown by means of sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) analysis.
Fig 2. Complete deficiency of type III collagen (a 1[III])
in the patient is shown by means of densitometric analysis.
Fig 3. Electron microscopic findings (original magnifica-
tion, · 30,000) of the collagen fibrils. A, Normal: The col-
lagen fibrils have a homogeneous appearance. B, Patient:
The collagen fibrils also have a homogeneous appearance.
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It was revealed by means of genetic studies on the
pathogenesis of EDS type IV that the deficient biosyn-
thesis of type III collagen is attributed to various
defects in the type III procollagen gene (COL3A1)10
and that this mutation in the type III procollagen gene
can cause familial aortic aneurysms10; however, we
cannot discuss the genetic alteration in our patients
because we did not examine their type III procollagen
gene, although if we had, there would have been some
genetic alteration. We will analyze the type III procol-
lagen gene next.
The outcome of surgical treatment for EDS type
IV patients is often poor because of the fragile aor-
tic wall caused by the deficiency of type III colla-
gen.11 Conversely, this patient and the patient in our
previous report1 did not have weak aortic walls, and
we did not encounter difficulties during surgery.
Therefore, as the prognosis is determined mainly by
the character of the aortic wall, it might be helpful
to examine the heterogeneity of the collagen fibrils
to aid in determining the prognosis of the patient.
Patients with aneurysms who have this new form
of type III collagen deficiency do not have the typ-
ical symptoms caused by type III collagen deficien-
cy. Therefore, it is difficult to distinguish this new
type of aneurysm from other aneurysms. The 2
cases we have encountered may represent a new
pathogenetic category of aneurysm. We are cur-
rently conducting further examinations, focusing
on aneurysms that occur in patients of a relatively
young age. 
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